Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_assertion type Assertion NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_head.
- NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_assertion description "[In conclusion, MAD2 is overexpressed frequently in hepatocellular carcinoma, including high-grade dysplastic nodules and early-stage small hepatocellular carcinoma, indicating that overexpression of MAD2 plays a role in the development and progression of hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_provenance.
- NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_assertion evidence source_evidence_literature NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_provenance.
- NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_assertion SIO_000772 18715617 NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_provenance.
- NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_assertion wasDerivedFrom befree-2016 NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_provenance.
- NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_assertion wasGeneratedBy ECO_0000203 NP688728.RANft5BY1FZA_hSEGTzMegCYgmutuxsnjBU4F35XXsGrw130_provenance.